Form D · Biotechnology

TRANSAVE INC

Monmouth Jct., NJ · CIK 0001118616

Offering snapshot reported Sep 28, 2010 · SEC filing

Reported sold
$2M
Offering amount: $6M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 17, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 28, 2010Initial$2,000,000No comparison0SEC filing
Jun 25, 2010Initial$5,499,999No comparison0SEC filing
Nov 3, 2009Initial$5,542,573No comparison0SEC filing
Sep 9, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 28, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Mar 6, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-148242

Source: Form D, filed Sep 28, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alex Barkas Director
Mark G. Cipriano Director
Renu Gupta Executive
Nicholas Gurreri Executive
Donald Hayden, Jr. Director
Richard S. Kollender Director
Stephen H.C. Kraus Director
Geert Jan Mulder Director
Walter Perkins Executive
Michio Soga Executive
Robert Weisskoff Director
Timothy Whitten Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11 Deer Park Drive Suite 117
Monmouth Jct., NJ, 08852